These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 26390952)

  • 1. European Code against Cancer 4th Edition: Medical exposures, including hormone therapy, and cancer.
    Friis S; Kesminiene A; Espina C; Auvinen A; Straif K; Schüz J
    Cancer Epidemiol; 2015 Dec; 39 Suppl 1():S107-19. PubMed ID: 26390952
    [TBL] [Abstract][Full Text] [Related]  

  • 2. European Code against Cancer 4th Edition: Process of reviewing the scientific evidence and revising the recommendations.
    Minozzi S; Armaroli P; Espina C; Villain P; Wiseman M; Schüz J; Segnan N
    Cancer Epidemiol; 2015 Dec; 39 Suppl 1():S11-9. PubMed ID: 26439654
    [TBL] [Abstract][Full Text] [Related]  

  • 3. European Code against Cancer 4th Edition: Infections and Cancer.
    Villain P; Gonzalez P; Almonte M; Franceschi S; Dillner J; Anttila A; Park JY; De Vuyst H; Herrero R
    Cancer Epidemiol; 2015 Dec; 39 Suppl 1():S120-38. PubMed ID: 26589774
    [TBL] [Abstract][Full Text] [Related]  

  • 4. European Code against Cancer 4th Edition: Ionising and non-ionising radiation and cancer.
    McColl N; Auvinen A; Kesminiene A; Espina C; Erdmann F; de Vries E; Greinert R; Harrison J; Schüz J
    Cancer Epidemiol; 2015 Dec; 39 Suppl 1():S93-100. PubMed ID: 26126928
    [TBL] [Abstract][Full Text] [Related]  

  • 5. European Code against Cancer 4th Edition: 12 ways to reduce your cancer risk.
    Schüz J; Espina C; Villain P; Herrero R; Leon ME; Minozzi S; Romieu I; Segnan N; Wardle J; Wiseman M; Belardelli F; Bettcher D; Cavalli F; Galea G; Lenoir G; Martin-Moreno JM; Nicula FA; Olsen JH; Patnick J; Primic-Zakelj M; Puska P; van Leeuwen FE; Wiestler O; Zatonski W;
    Cancer Epidemiol; 2015 Dec; 39 Suppl 1():S1-10. PubMed ID: 26164654
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Menopause and oncologic risks].
    Letendre I; Lopes P
    J Gynecol Obstet Biol Reprod (Paris); 2012 Nov; 41(7 Suppl):F33-7. PubMed ID: 23062839
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oestrogen and progestogen hormone replacement therapy for peri-menopausal and post-menopausal women: weight and body fat distribution.
    Norman RJ; Flight IH; Rees MC
    Cochrane Database Syst Rev; 2000; (2):CD001018. PubMed ID: 10796730
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer. Collaborative Group on Hormonal Factors in Breast Cancer.
    Lancet; 1997 Oct; 350(9084):1047-59. PubMed ID: 10213546
    [TBL] [Abstract][Full Text] [Related]  

  • 9. European Code against Cancer, 4th Edition: Cancer screening.
    Armaroli P; Villain P; Suonio E; Almonte M; Anttila A; Atkin WS; Dean PB; de Koning HJ; Dillner L; Herrero R; Kuipers EJ; Lansdorp-Vogelaar I; Minozzi S; Paci E; Regula J; Törnberg S; Segnan N
    Cancer Epidemiol; 2015 Dec; 39 Suppl 1():S139-52. PubMed ID: 26596722
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Latin America and the Caribbean Code Against cancer 1st edition: Environment, occupation, and cancer.
    Blanco E; Algranti E; Cifuentes LA; López-Carrillo L; Mora AM; Rodríguez-Guzmán J; Rodríguez-Villamizar LA; Veiga LHS; Canelo-Aybar C; Nieto-Gutierrez W; Feliu A; Espina C; Ferreccio C
    Cancer Epidemiol; 2023 Oct; 86 Suppl 1():102381. PubMed ID: 37852723
    [TBL] [Abstract][Full Text] [Related]  

  • 11. European Code against Cancer 4th Edition: Alcohol drinking and cancer.
    Scoccianti C; Cecchini M; Anderson AS; Berrino F; Boutron-Ruault MC; Espina C; Key TJ; Leitzmann M; Norat T; Powers H; Wiseman M; Romieu I
    Cancer Epidemiol; 2015 Dec; 39 Suppl 1():S67-74. PubMed ID: 26115567
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The risks and benefits of hormonal replacement therapy in healthy women and in breast cancer survivors.
    Welnicka-Jaskiewicz M; Jassem J
    Cancer Treat Rev; 2003 Oct; 29(5):355-61. PubMed ID: 12972354
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hormone replacement therapy for women previously treated for endometrial cancer.
    Edey KA; Rundle S; Hickey M
    Cochrane Database Syst Rev; 2018 May; 5(5):CD008830. PubMed ID: 29763969
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hormone replacement therapy and the breast.
    Dixon JM
    Surg Oncol; 2003 Dec; 12(4):251-63. PubMed ID: 14998565
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hormone Replacement Therapy in Cancer Survivors - Review of the Literature.
    Deli T; Orosz M; Jakab A
    Pathol Oncol Res; 2020 Jan; 26(1):63-78. PubMed ID: 30617760
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hormone replacement therapy and breast cancer: revisiting the issues.
    DeGregorio MW; Taras TL
    J Am Pharm Assoc (Wash); 1998; 38(6):738-44; quiz 744-6. PubMed ID: 9861792
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The long-term risks and benefits of hormone replacement therapy.
    Hillard TC; Whitcroft S; Ellerington MC; Whitehead MI
    J Clin Pharm Ther; 1991 Aug; 16(4):231-45. PubMed ID: 1939402
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical evidence supporting the rationale for constant oestrogen, intermittent progestogen hormone replacement therapy.
    Rozenberg S
    Eur J Obstet Gynecol Reprod Biol; 2001 Jan; 94(1):86-91. PubMed ID: 11134831
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hormone replacement therapy in the post-Women's Health Initiative era. Report a a meeting held in Funchal, Madeira, February 24-25, 2003.
    Burger H
    Climacteric; 2003 May; 6 Suppl 1():11-36. PubMed ID: 12945798
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.